Roger Pearse in New York, New York

Additional Medical Specialties Include:
HEMATOLOGY, INTERNAL MEDICINE

Medical School: Js Weill Medical College, Cornell University
Graduation Year: 1986
The Primary Medical Specialty for Roger Pearse is listed as: Medical Oncology
Approximate Years of Experience: 38
PAC (PECOS ID)#: 5193856094
NPI #: 1518057785
NPI Created On: 10/16/2006
NPI Last Updated Listed as: 09/16/2011
Primary Taxonomy Code: 207R00000X
License Number:
173349
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis
4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
8. Infusion of chemotherapy into a vein up to 1 hour
9. Infusion of chemotherapy into a vein
10. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
11. New patient office or other outpatient visit, typically 60 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Established patient office or other outpatient, visit typically 40 minutes
15. Initial hospital inpatient care, typically 70 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
18. Injection, denosumab, 1 mg
19. Injection, dexamethasone sodium phosphate, 1 mg
20. Injection, diphenhydramine hcl, up to 50 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).